Boothbay Fund Management »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.9M 3.9M 1.77
2023-06-30 $4.4M 2.5M 1.75
2021-03-31 $5.6M 4.3M 1.30

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr 1 3 Yr Treas Bd Put Option (SHY)
Vmware Cl A Com Call Option
Activision Blizzard
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Sarepta Therapeutics (SRPT)
Cornerstone Strategic Value (CLM)
Zimmer Holdings (ZBH)
Synopsys Put Option (SNPS)
Sprott Physical Gold & Silve Tr Unit (CEF)
Argenx Se Sponsored Adr (ARGX)
Select Sector Spdr Tr Indl Put Option (XLI)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Elanco Animal Health (ELAN)

View all positions for Boothbay Fund Management

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
Point72 Asset Management
D. E. Shaw & Co
CSS
Capstone Investment Advisors
Worth Venture Partners
Bank of America Corporation
Warberg Asset Management
Palisade Capital Management
Wolverine Asset Management
Leucadia National Corporation
Bnp Paribas Arbitrage, Snc
Fox Hill Wealth Management
Virtus Investment Advisers
Royal Bank of Canada

View all funds holding Sarepta Therapeutics note 1.500% 11/1